Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 58, Issue 1, 2018, Pages 22-39

  Qassim, Alaa ^a   Mol, Ben W ^b   Grivell, Rosalie M ^b,c,d   Grzeskowiak, Luke E ^b,c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

anemia; ferric compounds administration and dosage; iron deficiency drug therapy; pregnancy; treatment outcome

Indexed keywords

FERRIC CARBOXYMALTOSE; HEMOGLOBIN; IRON POLYMALTOSE; IRON SACCHARATE; FERRIC ION; MALTOSE;

CLINICAL OUTCOME; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MEDLINE; OBSTETRIC DELIVERY; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCOPUS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY COMPLICATION;

ADMINISTRATION, INTRAVENOUS; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; FERRIC OXIDE, SACCHARATED; HUMANS; MALTOSE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; QUALITY OF LIFE;

EID: 85041729618     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12695     Document Type: Review

References (67)

1. Stevens GA, Finucane MM, De-Regil LM et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health 2013; 1: e16–e25.
2. Haider BA, Olofin I, Wang M et al. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013; 346: f3443.
3. Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ 1995; 310: 489–491.
4. Scholl TO. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev 2011; 69: S23–S29.
5. Chang S, Zeng L, Brouwer ID et al. Effect of iron deficiency anemia in pregnancy on child mental development in rural China. Pediatrics 2013; 131: e755–e763.
6. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000; 71: 1280s–1284s.
7. Rasmussen KM. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality? J Nutr 2001; 131: 590S–603S.
8. Balk EM, Chung M, Hadar N et al. Accuracy of Data Extraction of Non-English Language Trials With Google Translate. Methods Research Report. (Prepared by the Tufts Evidence-based Practice Center under Contract No. 290-2007-10055 I.) AHRQ Publication No. 12-EHC056-EF. Rockville, MD: Agency for Healthcare Research and Quality. April 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm. 2012.
9. Higgins JP, Altman DG, Gøtzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
10. Kim SY, Park JE, Lee YJ et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 2013; 66: 408–414.
11. Froessler B, Cocchiaro C, Saadat-Gilani K et al. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fetal Med 2013; 26: 654–659.
12. Kriplani A, Mahey R, Dash BB et al. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res 2013; 138: 78–82.
13. Christoph P, Schuller C, Studer H et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med 2012; 40: 469–474.
14. Al RA, Unlubilgin E, Kandemir O et al. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 2005; 106: 1335–1340.
15. Tariq N, Ayub R, Khan W et al. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: A randomized controlled trial. J Coll Physicians Surg Pak 2015; 25: 193–197.
16. Gupta A, Manaktala U, Rathore AM. A randomised controlled trial to compare intravenous iron sucrose and oral iron in treatment of iron deficiency anemia in pregnancy. Indian J Hematol Blood Transfus 2014; 30: 120–125.
17. Dewan B, Philipose N, Balasubramanian A. Assessment of intravenous iron sucrose in the management of anemia in gynecological and obstetrical practice. J Obstet Gynaecol India 2012; 62: 281–285.
18. Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron–sucrose complex. Br J Nutr 2002; 88: 3–10.
19. Govan A, Scott J. Intravenous iron in the treatment of anaemia of pregnancy. Lancet 1949; 253: 14–16.
20. Akther R, Afroj H. Use of iron sucrose complex in treatment of anemia in pregnancy. Bangladesh J Obstet Gynecol 2010; 25: 20–23.
21. Nicholson D, Assali N. The hematologic response of the pregnant woman to intravenous saccharated iron oxide. Surg Gynecol Obstet 1952; 94: 513–518.
22. Holly RG. Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology. Blood 1951; 6: 1159–1172.
23. Raja K, Janjua N, Khokhar N. Intravenous iron sucrose complex therapy in iron deficiency anemia in the pregnant woman. Rawal Med J 2003; 28: 40–43.
24. Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Community Med 2012; 37: 214–218.
25. Dhanani JV, Ganguly B, Chauhan L. Comparison of efficacy and safety of two parenteral iron preparations in pregnant women. J Pharmacol Pharmacother 2012; 3: 314–319.
26. Aggarwal RS, Mishra V, Panchal NA et al. Evaluation of iron sucrose and oral iron in management of iron deficiency anaemia in pregnancy. Natl J Community Med 2012; 3: 55–60.
27. Bhargava R, Maheshwari M. Evaluation of intravenous iron versus oral iron in management of iron deficiency anemia in pregnancy with specific reference to body iron store. J Evol Med Dent Sci 2013; 2: 2750–2756.
28. Wali A, Mushtaq A. Comparative study–efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. J Pak Med Assoc 2002; 52: 392–395.
29. Mehta M, Shah J. Iron deficiency anemia in pregnancy: intravenous versus oral route. Natl J Community Med 2014; 5: 10–12.
30. Breymann C, Richter C, Huttner C et al. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000; 30: 154–161.
31. Bayoumeu F, Subiran-Buisset C, Baka N-E et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 2002; 186: 518–522.
32. Al-Momen A-K, Al-Meshari A, Al-Nuaim L et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol 1996; 69: 121–124.
33. Shrivastava D, Inamdar S, Bhute S, Singh A. Effectiveness of intravenous iron sucrose in management of iron-deficient anemia of pregnancy at rural hospital set up. J Obstet Gynaecol India 2012; 2013: 1.
34. Halimi S, Halimi SMA, Shoaib M. Oral versus parenteral iron therapy for correction of iron deficiency anaemia in pregnancy. Gomal J Med Sci 2010; 9: 3–5.
35. Shafi D, Purandare SV, Sathe A. Iron deficiency anemia in pregnancy: intravenous versus oral route. J Obstet Gynaecol India 2012; 62: 317–321.
36. Divakar H, Kumar N, Manyonda I. O228 Rapid versus slow intravenous iron sucrose administration in pregnant women with iron deficiency anemia in a rural setting in India. Int J Gynaecol Obstet 2009; 107: S158.
37. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res 2013; 39: 504–510.
38. Singh S, Singh S, Singh P. A study to compare the efficacy and safety of intravenous iron sucrose and intramuscular iron sorbitol therapy for anemia during pregnancy. J Obstet Gynaecol India 2013; 63: 18–21.
39. Abhilashini G, Sagili H, Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy. J Clin Diagn Res 2014; 8: 4–7.
40. Thakor N, Bhagora S, Asari U et al. Effect of intravenous iron sucrose therapy for moderate-to-severe anemia in pregnancy: a longitudinal study. Int J Med Sci Public Health 2015; 4: 11–14.
41. Patel S, Goyal A, Shrivastava A, Verma R. Safety and efficacy of parenteral iron sucrose complex therapy in iron deficiency anemia in antenatal and postnatal women. Int J Med Sci Public Health 2013; 2: 360–363.
42. Briscoe C. The use of intravenous iron in the practice of obstetrics and gynaecology. Am J Obstet Gynecol 1952; 63: 99–107.
43. Evans GE, Waltman R. The use of intravenous saccharated oxide of iron in obstetrics and gynecology. Am J Obstet Gynecol 1953; 66: 118–123.
44. Naz F, Iqbal K, Afreen N et al. Efficacy of intravenous iron sucrose therapy in iron deficiency anaemia of pregnancy. Pak J Med Health Sci 2010; 4: 130–133.
45. Kartchner FD, Holmstrom E. The treatment of iron deficiency anemia of pregnancy with intravenous iron. Am J Obstet Gynecol 1950; 60: 1288–1297.
46. Bare WW, Sullivan AA. Comparison of intravenous saccharated iron oxide and whole blood in treatment of hypochromic anemia of pregnancy. Am J Obstet Gynecol 1960; 79: 279–285.
47. Sortor R. Intravenous iron as an alternative to blood transfusion in late pregnancy. Am J Obstet Gynecol 1957; 73: 338–340.
48. Scott J, Govan A. Anaemia of pregnancy treated with intravenous iron. Lancet 1951; 1: 367–370.
49. Gupta A, Rathore AM, Manaktala U et al. Role of intravenous iron sucrose in correction of anemia in antenatal women with advanced pregnancy. Indian J Hematol Blood Transfus 2015; 31: 251–254.
50. Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol 2016; 5: 747–751.
51. Shah R, Modi K, Patel S et al. Role of injectable iron sucrose in pregnancy beyond 26 weeks. Indian J Appl Res 2016; 5: 31–32.
52. Myers B, Myers O, Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron (III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med 2012; 5: 105–107.
53. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth 2014; 14: 1.
54. Pels A, Ganzevoort W. Safety and efficacy of ferric carboxymaltose in anemic pregnant women: a retrospective case control study. Obstet Gynecol Int 2015; 2015: 728952.
55. Sogbanmu M. Anaemia of pregnancy treated with total-dose infusion of iron-polymaltose complex, teferrol. Curr Ther Res Clin Exp 1976; 20: 149–155.
56. Khalafallah A, Dennis A, Bates J et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010; 268: 286–295.
57. ®) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy. Eur J Haematol 1998; 60: 119–124.
58. Khalafallah AA, Dennis AE, Ogden K et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open 2012; 2: e000998.
59. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011; 5: CD003094.
60. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 2013; 347: f4822.
61. Avni T, Bieber A, Grossman A et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 2015; 90: 12–23.
62. Blazar AS, Del Riego MG. Severe idiosyncratic reactions to an intravenous iron preparation. Obstet Gynecol 1962; 20: 156–159.
63. Mishra A, Dave N, Viradiya K. Fatal anaphylactic reaction to iron sucrose in pregnancy. Indian J Pharmacol 2013; 45: 93.
64. Grzeskowiak LE, Qassim A, Jeffries B, Grivell RM. Approaches for optimising intravenous iron dosing in pregnancy: a retrospective cohort study. Intern Med J 2017; 47: 747–753.
65. Daru J, Cooper NA, Khan KS. Systematic review of randomized trials of the effect of iron supplementation on iron stores and oxygen carrying capacity in pregnancy. Acta Obstet Gynecol Scand 2016; 95: 270–279.
66. Qassim A, Gergis RG, Jeffries B et al. Use of intravenous iron polymaltose in the management of iron deficiency in pregnancy: a retrospective cohort study. Aust N Z J Obstet Gynaecol 2017; https://doi.org/10.1111/ajo.12645.
67. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015; 7: CD004736.